Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
| Image |  |
|---|---|
| Description | scholarly article by Andrew Spencer et al published 20 September 2018 in Haematologica |
| Author/s | |
| Publication date | September 20, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |